Trump’s drug-pricing proposal a step forward, but may not have significant impact

The Trump Administration proposed a new rule last week to lower prices of prescription drugs and out-of-pocket costs by encouraging manufacturers to offer direct discounts to patients, according to a press release issued by HHS.
“Every day, Americans — particularly our seniors — pay more than they need to for their prescription drugs because of a hidden system of kickbacks to middlemen,” Alex Azar, HHS Secretary, said in the release. “President Trump is proposing to end this era of backdoor deals in the drug industry, bring real transparency to drug (Read more...)

Full Story →